Navigation Links
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Date:8/4/2009

ber 31, 2008 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements. NEKTAR THERAPEUTICS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (unaudited) Six Months Ended June 30, ---------------- 2009 2008 ---- ---- Cash flows from operating activities: Net loss $(63,876) $(74,080) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 7,359 11,820 Stock-based compensation 4,691 3,863 Other non-cash transactions 56 (309) Changes in assets and liabilities: Decrease (increase) in trade accounts receivable 2,362 9,570 Decrease (increase) in inventory (791) 2,021 Decrease (increase) in other assets 1,284 (6,026) Increase (decrease) in accounts payable (5,513) (1,727) Increase (decrease) in accrued compensation (4,687) (3,676) Increase (decrease) in accrued clinical trial expenses (5,512) 10,160 Increase (decrease) in accrued expenses (1,344) (1,061) Increase (decr
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 Using publicly released ... health plan costs for five common specialty drugs. ... consumers given their high costs and shortage of ... cost thousands per prescription, and are used for ... and multiple sclerosis. HealthPocket found ...
(Date:8/26/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and its associated ... to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 ... affects more than 100,000 Americans. As this disease ... gradually lose the ability to breathe, leading ultimately ...
(Date:8/26/2014)... NEW YORK and LONDON ...   FDNA Inc. ( http://www.fdna.com ) ... today that they have partnered to offer, for the ... exclusively through FDNA,s solutions. FDNA, developer of ... fully integrate LMD,s award-winning collection into Face2Gene [ ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... ATLANTA, June 7, 2011 CardioMEMS, Inc ., an ... a proprietary wireless sensing and communication technology for the human ... Yadav, M.D. , is a finalist for the 25th annual ... Entrepreneur category. The awards are sponsored by the Metro Atlanta ...
... June 7, 2011 The ALS Therapy Development Institute ... Michael Capuano (D-MA) with its first ever "Lou Gehrig ... gala event this November 3rd.  The award recognizes ... advocate for additional funding for research leading to an ...
Cached Medicine Technology:Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 2Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 3U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November 2
(Date:8/27/2014)... 2014 PCOS (Polycystic Ovarian Syndrome) affects ... at risk for a number of health disorders and ... well understood even within the medical community. Many women ... (hirsutism) and excess body fat around the waist area ... problems are caused by PCOS. , Awareness is the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... PartnerTech AB, a major systems integration and electronics ... Cryotherapy offering the first U.S. designed and ... offered the ideal combination of manufacturing expertise, location, ... system. Impact Cryotherapy, headquartered in Atlanta, GA, offers ...
(Date:8/27/2014)... DeLand, FL (PRWEB) August 27, 2014 *Anyone who ... in DeLand, FL can visit Avail Clinical Research on the web ... Fibromyalgia , Over 5 million Americans are affected by fibromyalgia – ... such as:, Chronic widespread pain , ... Chronic fatigue and sleep problems , Depression , ...
(Date:8/26/2014)... Co (PRWEB) August 27, 2014 Carol ... new cookbook— 100 Best Quick Gluten-Free Recipes (Houghton ... gluten-free meals. , Fenster believes that cooking gluten-free ... understands how today’s busy lifestyle doesn’t leave much time ... that gluten-free cooks ask me is how to shorten ...
(Date:8/26/2014)... Wauwatosa, WI (PRWEB) August 27, 2014 AlignLife ... the month of July. "We had a goal to collect ... Force", Dr. Sara Mahalko said. "Our patients helped us not ... our goal." AlignLife of Wauwatosa collected 559lbs of ... the bar high for next year," explains Dr. Katie Sam. ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2
... that are commonly referred to as non-communicable diseases could cause ... of the health care cost by 2015, according to estimates ... million people in 2005 to NCD, the toll might reach ... Robert Beaglehole, director of NCD, WHO. ,He was ...
... Pradesh, 136 have been found to be due to ... announced this shocking report in the Assembly. ... identify individuals/health organizations involved in the controversial blood transfusion ... would be implemented to avoid such instances in the ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... AIDS/HIV, which is haunting the world for over two decades ... countries in the Asia Pacific // Region would meet in ... treatment and prevention would be the main focus of the ... target to expand AIDS treatment to over 3 million universal ...
... the second leading cause of blindness, worldwide would affect 60 ... end of 2020, // based on a projection in the ... and Africa would be the worst affected by the disabling ... of all glaucoma cases by then. Six out of ...
... treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. ... U.S. Food and Drug Administration said that the drug ... from blood-sugar changes due to this drug. ... of serious cases of hypoglycemia (low blood sugar) and ...
Cached Medicine News:
Athouritative, on the spot answers for acute care and consultations....
The workhorse electric system....
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
Medicine Products: